Skip to main content
Vivesto logo

Vivesto — Investor Relations & Filings

Ticker · VIVE ISIN · SE0000722365 LEI · 5493003TZPR4B7QO9L49 ST Manufacturing
Open in API
Filings indexed 1,068 across all filing types
Latest filing 2022-03-31 Declaration of Voting R…
Country SE Sweden
Listing ST VIVE

About Vivesto

https://www.vivesto.com/en/

Vivesto is a specialty pharmaceutical company focused on drug development in oncology. The company aims to provide new therapeutic options for patients suffering from hard-to-treat cancers where significant medical needs exist. Its research and development efforts are centered on creating innovative treatments and enhancing the intravenous delivery of established and novel drugs. The company's lead product is Apealea, a formulation of the cancer drug paclitaxel.

Recent filings

Filing Released Lang Actions
Nytt antal aktier och röster i Vivesto
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly announces a change in the total number of shares and votes following a rights issue registration. It states the new total count (496,736,666 shares) and the increase in share capital. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA). Although it is a short announcement, the core content is the capital change itself, not just the announcement of a report, making SHA a better fit than RPA or RNS.
2022-03-31 Swedish
New number of shares and votes in Vivesto
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly announces an increase in the total number of shares and votes following the registration of a new issue with preferential rights. It states the new total share count and the resulting increase in share capital. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA). Although it is a short announcement, the core content is the capital change itself, not just the announcement of a report, making SHA a better fit than RPA or RNS.
2022-03-31 English
FINAL RESULT OF OASMIA’S RIGHTS ISSUE
Capital/Financing Update Classification · 98% confidence The document is titled "FINAL RESULT OF OASMIA'S RIGHTS ISSUE" and details the subscription rates, allotment process, and resulting capital increase from a rights issue announced previously. A rights issue is a corporate action related to fundraising and capital structure changes. This directly aligns with the definition of 'Capital/Financing Update' (CAP). Although it announces the final result, the content is substantive financial/structural information about the capital change, not just a brief announcement of a report's availability, making CAP more specific than RPA or RNS.
2022-03-25 English
SLUTLIGT RESULTAT AV OASMIAS FÖRETRÄDESEMISSION
Capital/Financing Update Classification · 98% confidence The document is titled "SLUTLIGT RESULTAT AV OASMIAS FÖRETRÄDESEMISSION" (Final Result of Oasmia's Rights Issue). It details the outcome of a previously announced rights issue (Företrädesemission), including the number of shares subscribed, allocation to guarantors, the resulting increase in share capital, and the timeline for trading new shares. This content directly relates to changes in the company's capital structure and fundraising activities. This fits the definition of 'Capital/Financing Update' (CAP). Although it announces the final result, the document itself contains the substantive details of the capital change, making it more specific than a general 'Report Publication Announcement' (RPA) or 'Regulatory Filing' (RNS).
2022-03-25 Swedish
PRELIMINÄRT RESULTAT AV OASMIAS FÖRETRÄDESEMISSION
Share Issue/Capital Change Classification · 99% confidence The document is a press release titled "PRELIMINÄRT RESULTAT AV OASMIAS FÖRETRÄDESEMISSION" (Preliminary Result of Oasmia's Rights Issue). It details the outcome of a rights issue (a capital raising activity), including the percentage subscribed, the amount raised (approx. 151 million SEK), and the resulting increase in share capital and total number of shares. This content directly relates to financing activities and capital structure changes. This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it is a press release, the core subject matter is the financing event itself, not just an announcement that a report is available (which would suggest RPA or RNS). Since the document provides the substantive results of the capital raise, CAP is the most appropriate classification.
2022-03-24 Swedish
PRELIMINARY RESULT OF OASMIA’S RIGHTS ISSUE
Capital/Financing Update Classification · 98% confidence The document is titled "PRELIMINARY RESULT OF OASMIA'S RIGHTS ISSUE" and details the outcome of a fully secured rights issue, including the percentage subscribed, the amount of capital raised (SEK 151 million), and the resulting increase in share capital and total number of shares. This content directly relates to fundraising, capital structure changes, and the issuance of new shares following a rights offering. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP) or potentially 'Share Issue/Capital Change' (SHA). Since the core focus is the *result* of the financing activity (the Rights Issue), CAP is the most appropriate primary classification, as it covers fundraising activities. SHA is also relevant but CAP is broader for financing events. Given the detailed financial outcome of the capital raise, CAP is selected.
2022-03-24 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.